HBPCF fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. It also funds research through issuance of common shares and warrants. The company was founded by Jerome F. McElroy on July 31, 1995 and is headquartered in Toronto, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
HBPCF has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company